Boston Scientific touts CMS reimbursement nod for asthma treatment | Regulatory Roundup

January 4, 2012 by MassDevice staff

Boston Scientific's Alair bronchial thermoplasty system won pass-through payment approval from the Centers for Medicare & Medicaid Services.


Boston Scientific Corp.'s (NYSE:BSX) Alair asthma management system won reimbursement from the Centers for Medicare & Medicaid Services, effective at the start of this year.

The Alair system delivers precise thermal energy lung to tissue via bronchoscope to reduce excessively smooth muscle, decreasing the airway's ability to constrict.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.